The Paired Cord-and-Meconium Study Was Not a Survey of All Births
The forty-six specimen pairs came from archived cases in which both tests had been clinically ordered. Their cannabinoid-positive proportions were not population prevalence estimates.
Selection followed the availability of paired orders
Investigators sought residual meconium and cord tissue from the same newborn where testing for both matrices had been requested. Specimens were retrieved before disposal, de-identified and included regardless of their existing THC results. This avoided selecting solely on positivity, but it did not create a random sample of all births.
Paired design strengthened a specific comparison
Matching the two matrices to one birth helped examine differences in detection and analyte profiles. That design does not eliminate differences between tested families and families without either clinical test. The positivity counts should therefore retain their clinical-order context.
Agreement and prevalence remain separate questions
The study found discordant matrix results, but cannot establish how often prenatal cannabis exposure occurs in the general population. It also did not attach a specific developmental outcome to each concentration. A scientific opinion should distinguish a paired analytical comparison from an epidemiologic survey or an outcome-prediction study. Its value lies in characterizing the two specimen methods under actual clinical conditions, without extending the selected sample to every newborn.
Related analysis: the study’s broader findings and limitations.
